A recent Forbes article detailing RxAnte’s acquisition by Millenium Health further highlights RxAnte’s innovative work in transitioning predictive analytics in medication adherence from theory to reality: “There’s a lot of hype around predictive analytics,” says Josh Benner, RxAnte’s president. “It’s one thing to tell the future, and another to tell how to change it.”

Read the full article here.